Yury B Lishmanov Selected Research

Ala(2)- deltorphin II

1/2014	Activation of peripheral delta opioid receptors increases cardiac tolerance to arrhythmogenic effect of ischemia/reperfusion.
11/2010	Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction.
5/2009	Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yury B Lishmanov Research Topics

Disease

5	Infarction (Infarctions) 09/2018 - 05/2009
4	Ischemia 09/2018 - 09/2013
3	Hypoxia (Hypoxemia) 09/2018 - 09/2013
3	Reperfusion Injury 05/2015 - 05/2009
2	Myocardial Infarction 09/2013 - 11/2010
1	Acute Kidney Injury (Acute Renal Failure) 08/2016
1	Necrosis 01/2016
1	Ventricular Fibrillation 01/2014
1	Ventricular Tachycardia 01/2014
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2014
1	Ganglion Cysts (Ganglion) 05/2009

Drug/Important Bio-Agent (IBA)

6	Opioid Receptors (Opioid Receptor)IBA 01/2016 - 05/2009
3	Opioid Analgesics (Opioids)IBA 01/2016 - 09/2013
3	Ala(2)- deltorphin IIIBA 01/2014 - 05/2009
2	Nitric Oxide Synthase (NO Synthase)IBA 09/2018 - 05/2009
2	KATP ChannelsIBA 09/2018 - 05/2009
2	Glyburide (Glibenclamide)FDA LinkGeneric 09/2018 - 05/2009
2	GenisteinIBA 09/2018 - 05/2009
2	5-hydroxydecanoic acidIBA 09/2018 - 05/2009
2	Protein Kinase CIBA 09/2018 - 05/2009
2	mitochondrial K(ATP) channelIBA 09/2018 - 05/2009
2	Naltrexone (ReVia)FDA LinkGeneric 01/2014 - 09/2013
2	deltorphinIBA 01/2014 - 11/2010
2	N-methylnaloxoneIBA 01/2014 - 09/2013
2	naltrindole benzofuranIBA 01/2014 - 09/2013
1	chelerythrineIBA 09/2018
1	WortmanninIBA 09/2018
1	Tyrosine (L-Tyrosine)FDA Link 09/2018
1	S-methylisothiopseudouroniumIBA 09/2018
1	Tyrosine Kinase InhibitorsIBA 09/2018
1	HMR 1098IBA 09/2018
1	AtractylosideIBA 09/2018
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 09/2018
1	7-nitroindazoleIBA 09/2018
1	Phosphotransferases (Kinase)IBA 09/2018
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2018
1	Lipocalin-2IBA 08/2016
1	dermorphinIBA 01/2014
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2014
1	EnkephalinsIBA 01/2014
1	NociceptinIBA 01/2014
1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2014
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 01/2014
1	D-Penicillamine (2,5)- EnkephalinIBA 01/2014
1	maleic acid (maleate)IBA 01/2014
1	Mesylates (Mesylate)IBA 01/2014
1	norbinaltorphimineIBA 09/2013
1	ORALIT (ORS)IBA 09/2013
1	Opioid Peptides (Opioid Peptide)IBA 09/2013
1	Oxygen (Dioxygen)IBA 09/2013
1	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 09/2013
1	Nociceptin ReceptorIBA 11/2010
1	Coloring Agents (Dyes)IBA 11/2010
1	sulfan blue (patent blue V)IBA 11/2010
1	CatecholaminesIBA 05/2009
1	Hexamethonium (Hexamethonium Bromide)IBA 05/2009
1	Guanethidine FDA Link 05/2009
1	Adenosine Triphosphate (ATP)IBA 05/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2009